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Abstract
It has been recognised recently that obese individuals have lower concentrations of micronutrients and this may affect the concentrations
of inflammatory cytokines. A cross-sectional study was carried out to evaluate the association of specific micronutrients’ status with chronic
inflammation caused by obesity in 280 women (36·1 (SD 7·5) years) from seven rural communities in Mexico. Measurements of weight,
height and waist circumference were made on all women and body composition was determined by dual-energy X-ray absorptiometry.
Concentrations of the cytokines IL-1, TNF-a, IL-6, IL-10 and IL-12, lipid profile, and the micronutrients Zn and vitamins A, C and E
were determined in fasting blood samples. Ordered logistic regression models were used to determine associations between categorised
cytokine levels and micronutrients. It was found that 80 % of women were overweight or obese, and had significantly higher concen-
trations of C-reactive protein than normal-weight women (P¼0·05). The risk of higher levels of TNF-a, IL-6, IL-10 and IL-12 was reduced
significantly among women with higher Zn concentrations (OR 0·63, 95 % CI 0·42, 0·96, P¼0·03; OR 0·57, 95 % CI 0·39, 0·86, P¼0·025; OR
0·63, 95 % CI 0·41, 0·96, P¼0·04; OR 0·62, 95 % CI 0·41, 0·95, P¼0·03, respectively). Higher concentrations of vitamin A were slightly associ-
ated with reduced risks of higher levels of IL-1 and IL-12 (OR 0·97, 95 % CI 0·95, 0·99, P¼0·03; OR 0·97, 95 % CI 0·94, 0·99, P¼0·03, respect-
ively); when adjusting for BMI, this association was lost. No associations were found between vitamin C or vitamin E:lipids concentrations
and inflammatory cytokines. In conclusion, higher Zn concentrations are associated with reduced risks of higher concentration of inflam-
mation markers in a population of women with a high prevalence of obesity.
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The growing burden of obesity-associated chronic diseases is
now one of the more important health issues in the world.
Obesity and excess abdominal fat are risk factors for a broad
range of chronic diseases such as hypertension, CVD and
type 2 diabetes mellitus, all of which are now the principal
causes of mortality worldwide(1–3). The burden of this com-
plex of diseases is now becoming an acute problem in indus-
trialising countries passing through an epidemiological and
nutrition transition. Mexico, for example, is one of the
countries with the highest prevalence of obesity, as found in
a 2006 National Nutrition Survey of Mexico (Encuesta Nacional
de Salud y Nutricio´n; ENSANUT 2006), and this prevalence is
increasing year after year(4).
Obesity has been described as a form of low-grade inflam-
mation(5). Inflammatory cytokines such as TNF-a, IL-1 and
IL-6, which are important risk factors for chronic diseases,
are elevated in obese individuals. These cytokines are princi-
pally produced through signalling pathways located within the
adipocytes that make up the white adipose tissue. Their circu-
lating concentrations directly correlate with adipocyte size and
number(6). Leptin, an adipokine that promotes the sensation
of satiety, plays an important role in promoting the expression
of such inflammatory cytokines(7). Also, leptin is involved in
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the activation and infiltration of macrophages into white adi-
pose tissue(6), the activation of natural killer cells(8), and sup-
presses the proliferation of CD4þ and CD25þ Treg cells(9), and
also regulates the T-helper (Th) 1 and Th2 response(10).
Micronutrient status is associated with obesity and may have
an important effect on the inflammatory response(11). Studies
have shown that low Zn serum concentration is associated
with an increased risk of being obese(11). Zn may regulate the
inflammatory response by up-regulating leptin synthesis, by
directly activatingmonocytes, or through its role inZn-a2-glyco-
protein (ZAG) which is involved in TNF-a transcription(12,13). A
vitamin A-deficient diet in animal models is associated with
increased leptin expression in white adipose tissue and brown
adipose tissue(14,15). Vitamin A and its active metabolites inhibit
the inflammatory Th1 response and promote the Th2
response(16). Vitamin E has also been found to function as an
anti-inflammatory agent in studies concernedwith inflammation
and pulmonary function in asthma patients as well as inflam-
mation in rats with induced asthma(17,18). Vitamin C has been
shown to have anti-inflammatory effects by reducing C-reactive
protein (CRP) serumconcentrations(19,20). It is still not clearwhat
effect each micronutrient has on these inflammatory response
pathways among individuals who differ in adiposity and body
mass. Also, studies have shown that the intake of certain
foods, such as legumes, whole grains, fruits and vegetables,
that have a high content of micronutrients including Zn,
and vitamins A, C and E, have been associated with lower mar-
kers of inflammation(21–23).
The objective of the present study was to examine
how micronutrient blood concentrations and measures of
adiposity are associated with the inflammatory response
among Mexican women with a high prevalence of over-
weight and obesity. The further clarification of this relation-
ship could lead to the development of new preventive and
therapeutic micronutrient interventions that contribute to
the reduction in the burden of obesity and its complications.
Experimental methods
Study population
The population for this study was 280 women, 25–55 years
of age, who resided in six rural communities located within
the Mexican State of Quere´taro. Women were excluded from
the study if they had uncontrolled diabetes, if they had
received treatment for obesity or had taken vitamin and
mineral supplements in the previous 3 months. Pregnant
and lactating women, as well as women who had any type
of eating disorder, were also excluded from the study. The
present study was conducted according to the guidelines
laid down in the Declaration of Helsinki and all procedures
involving human subjects/patients were approved by the
Human Research Committee of the School of Natural Sciences
at the Universidad Auto´noma de Quere´taro (UAQ). Written
informed consent was obtained from all subjects/patients.
The sample size of 280 subjects in this study was intended
to find a significant OR of 0·50 or 1·75 between two indepen-
dent groups with different concentrations of cytokines, with
an a error of 5 %, b error of 20 %, and an estimated prevalence
of a micronutrient deficiency of 20 %(24).
Study design
This study was cross-sectional in design, in which all enrolled
women were first interviewed during an initial household
visit to determine clinical histories of chronic disease. Sub-
sequently, these women were then transported at different
dates to the Metabolic Unit at the School of Natural Sciences
within UAQ, where anthropometric and body composition
determinations were made in one session.
A single, basal 5 ml blood sample was drawn from
all women who had been fasting for the previous 12 h for
the determination of glucose concentrations, lipid profile,
Zn, vitamins A, C and E concentrations and concentrations
of inflammatory and adaptive immune response cytokines.
These samples were collected from the women, at the local
health clinic in their respective communities.
Anthropometry and body composition methods
The women wearing light clothing were weighed using a scale
(SECA ONDA Mod 843; SECA) with a precision of 1·0 g, while
their stature was determined with a precision of 0·1 cm using a
portable stadiometer (SECA Mod 206; SECA). Hip circumference
was determined with a precision of 0·1 cm using flexible metal
tapes (SECA Mod 200; SECA). All measurements were done,
non-consecutively, in duplicate by personnel, that had
been previously standardised in their application according
to procedures developed by Lohman et al.(25). Women
were then categorised as normal weight (BMI ,24·9 kg/m2),
overweight (BMI between 25·0 and 29·9 kg/m2) and obese
(BMI .30·0 kg/m2), using the WHO classification system(26,27).
Body composition determinations, percentage of body fat
and percentage of abdominal fat, were carried out during
this session using DEXA (Hologic, Mod Explorer) in the
Metabolic Unit of UAQ, by a certified technician. High body
fat was considered with values $30 % of total body mass(28).
Abdominal fat was obtained as described previously(29).
Briefly, abdominal fat is determined from a 10 cm rectangle
that is drawn in the X-ray body diagram, immediately above
the ileac crest of the subject and it is extended to the sides
over the border of the subject’s anatomy.
Laboratory methods
Leptin and C-reactive protein determinations. Concentra-
tions of leptin and CRP in plasma were measured in duplicate
using commercial ELISA kits (Human Leptin Elisa Kit,
Linco Research; High Sensitivity C-Reactive Protein Elisa Kit,
Bioquant).
Determination of inflammatory and adaptive immune
response cytokines. The concentrations of the inflammatory-
related cytokines, IL-1b, IL-6, IL-8, TNF and IL-12p70, and
the anti-inflammatory cytokine IL-10 were measured simul-
taneously using flow cytometry analysis with the human
inflammation kit (Becton Dickinson). Briefly, the serum
Micronutrients’ associations with cytokines in women 687
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samples (50ml) were incubated 1·5 h in the dark with the
appropriate dilution of the capture beads, which were then
washed by centrifugation and followed by their incubation
for an additional 1·5 h. The beads were then washed
again by centrifugation and quantified in a FACSCAN
(Becton Dickinson) equipped with a 488 nm laser. The data
were analysed using the BD CellQuest software, with positive
controls provided by the supplier.
Determination of zinc in plasma. Zn concentrations in
plasma were measured using flame atomic absorption spec-
trophotometry (Perkin Elmer, Mod. Analyst 700) using the
corresponding certified standards. Zn deficiency was defined
as plasma concentrations of , 700mg/l(30).
Determination of vitamins A, E and C in plasma. Vitamins
A and E were simultaneously determined by reversed-phase
HPLC (WATERS) using a C18 column (WATERS) with
a mobile phase of 100 % methanol (J. T. Baker) and a
1 ml/min flow with a temperature of 408C, measured at a
wavelength of 300 nm. Vitamin C was measured by HPLC
(WATERS), using a C18 column (WATERS) with a mobile
phase of 0·01 M-NaH2PO4 and 0·2 mM-EDTA, a 0·85 ml/min
flow, and measured at a wavelength of 254 nm.
Determination of glucose and lipid profile. Fasting glu-
cose concentration was measured by an enzymatic-
colorimetric method using the commercial kit Glucose-PAP
(Elitech) with a Clinical Analyser Bayer RA-50 (Bayer Diagnos-
tics). Plasma concentration of total cholesterol, HDL and total
TAG were measured using commercial kits (Cholesterol SL,
Triglycerides, Cholesterol HDL SL 2G, Elitech) in a Bayer
RA-50 Analyzer (Bayer Diagnostics). LDL was calculated
from the previously mentioned data using the Friedewald
method(31).
Biochemical and immunological assays of all samples were
carried out in duplicate in the Human Nutrition Laboratory
in the School of Natural Sciences at UAQ.
Data analysis
Data were entered in Excel (Microsoft), verified, and checked
for range and consistency. Women were considered Zn-defi-
cient if they had plasma concentrations below 700mg/l(30),
and vitamin A-deficient if they had plasma concentrations
,200mg/l(32). Women were classified as vitamin E-deficient
if they had concentrations ,5mg/ml or ,2·4mmol a-toco-
pherol:mmol lipid, and finally, vitamin C-deficient if they
had plasma concentrations ,2mg/ml(32,33). Women were
classified as having high glucose if they had a fasting plasma
concentration of glucose above 1260 mg/l(34). Women
were classified with normal lipid concentration if they had
cholesterol , 2000 mg/l, TAG ,1500 mg/l and HDL-choles-
terol .350 mg/l(35).
The primary end points for this analysis were the plasma
concentrations of pro- and anti-inflammatory cytokines and
chemokines among all enrolled women from whom blood
samples were taken. Means and standard deviations of physi-
cal and biochemical characteristics of enrolled women were
first determined to summarise the data.
Associations between measures of obesity, total body fat in
kg and percentage, and abdominal fat and plasma concen-
trations of the pro-inflammatory cytokines IL-1, IL-6, IL-8,
IL-12, TNF-a and the anti-inflammatory cytokine IL-10 cyto-
kine were determined as a first step in the overall analysis.
Conventional analytical techniques could not be used to
analyse these cytokines as endpoints, since an important
proportion of samples had no detectable concentration of
cytokines. Accordingly, ordered logistic regression analyses
were used, which models the probability distributions of cyto-
kine values categorised into three levels ordered from lowest
to highest: undetectable, ,median of positives, .median of
positives(36). The inclusion of BMI, abdominal fat (%) and
waist-to-height index in the model tested the hypothesis that
the probability distributions of categorised cytokine values
will differ according to differences in these measures
expressed as an OR. Ordinal logistical analyses were then
carried out to determine the associations between leptin
with the pro-inflammatory and anti-inflammatory cytokines.
Leptin analysis was controlled for age and CRP concentrations.
These analyses were meant to determine whether leptin is
the intermediate mechanism underlying the associations
between measures of obesity and body fat and cytokine
plasma concentrations.
A final set of analyses was then carried out to test the
hypothesis that the probability distributions of categorised
cytokine values will vary by differences in the micronutrient
plasma concentration again expressed as an OR. As such,
analyses were first carried out with the variables for plasma
concentrations of vitamin A, vitamin C, vitamin E adjusted
for lipids, and Zn included separately in models for each cyto-
kine. Models were then run, which included all the micronu-
trient variables together in models for each cytokine to control
for any interactions between the different micronutrients ana-
lysed. Thus, results are presented adjusted for micronutrient
concentrations all together, age and CRP concentrations,
and further adjusted for BMI. Statistical significance was set at
a probability level of ,0·05 and ,0·1 for interactions. Data
were analysed using ordered logistics procedure (OLOGIT)
in the STATA (version 10) software (STATACorp LP).
Results
A total of 280 women were enrolled in the study. The anthro-
pometric and metabolic characteristics of the women at the
beginning of the study are summarised in Table 1. The preva-
lence of obesity and overweight was 43·9 and 36·4 %, respect-
ively. In addition, 21·7 % had hypertriacylglycerolaemia,
37·8 % had high total cholesterol and 11·8 % of the women
had low levels of HDL. Overall, 4, 15·5 and 16·7 % of
women had deficiencies of vitamin C, vitamin E and Zn,
respectively, while no women were found to have vitamin A
deficiency. When adjusting for total lipids, 11 % of the parti-
cipants had vitamin E deficiency.
Ordered logistical regression models were first used to
analyse the associations between measures of obesity and
adiposity with probability of higher cytokine and chemokine
levels. Women with higher BMI, a greater percentage of
G. Zavala et al.688
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abdominal fat or a greater waist-to-height index were found
to have an increased probability of having higher con-
centrations of IL-6 (OR 1·05, 95 % CI 1·01, 1·09, P¼0·01;
OR 1·03, 95 % CI 1·00, 1·07, P¼0·05 and OR 12·89, 95 % CI
0·92, 179·5, P¼0·04, respectively). No significant association
was found between increased odds for the other cytokines
and other anthropometric measures of obesity (Table 2).
No association was found between leptin and cytokines
when included in the models.
The ordered logistical regression models were then used to
analyse the associations between serum micronutrient concen-
trations and the probability of higher cytokine and chemokine
concentrations. The OR of having higher concentrations of
TNF-a, IL-6, IL-10 and IL-12 were reduced for women with
higher concentrations of plasma Zn (OR 0·63, 95 % CI 0·42,
0·96, P¼0·03; OR 0·57, 95 % CI 0·39, 0·86, P¼0·025; OR 0·63,
95 % CI 0·41, 0·96, P¼0·04 and OR 0·62, 95 % CI 0·41, 0·95,
P¼0·03, respectively) (Table 3). Higher concentrations of
vitamin A were associated with reduced risks of higher
levels of IL-1 and IL-12 (OR 0·97, 95 % CI 0·95, 0·99, P¼0·03;
OR 0·97, 95 % CI 0·94, 0·99, P¼0·03, respectively). This associ-
ation disappears when adjusting for BMI. No associations
between inflammation markers and vitamin C or vitamin E
adjusted for lipids were found.
Discussion
The present study has characterised the relationship between
inflammatory cytokine markers and measures of obesity and
adiposity among women, and also how serum concentrations
of micronutrients are associated with inflammatory cytokine
markers. Higher concentrations of plasma Zn were associated
with reduced levels of inflammatory cytokines.
The significant association found between IL-6 and
measures of obesity and body composition is consistent with
other studies which have found that this cytokine is associated
with adiposity(37). Mohamed-Ali et al.(38), for example,
reported that approximately 30 % of in vivo circulating levels
of IL-6 was secreted by adipose tissue and that this release
was greater in obese subjects. Vozarova et al.(39) also found
that fasting plasma IL-6 concentrations were positively related
to adiposity but negatively related to insulin action in Pima
Indians. In contrast to our findings, TNF-a also has been
reported to be significantly elevated in obese, insulin-resistant
rodents and humans(40,41). However, Kern et al.(41), reported
that IL-6 levels were much higher in both adipose tissue and
plasma in obese subjects while no significant differences in
TNF-a secretion by adipose tissue depots was found between
obese and lean subjects. These inconsistent observations sup-
port the lack of association for this cytokine and adiposity
measures found in the present study.
The lack of correlation between leptin levels with any of the
inflammation cytokine markers is not consistent with reports
from other studies(42). However, the relationship between
leptin and inflammatory cytokines reported in previous
studies is not always consistent. For example, an inverse
relationship between leptin and IL-6 as well as other inflam-
mation markers was found among rheumatoid arthritis
patients(43). In vitro studies of human and rat monocytes
have also found that leptin enhances the expression of pro-
inflammatory cytokines like IL-6, IL-8 and TNF-a(44,45). Xiao
et al.(46), in contrast, reported a reduction in IL-6 and TNF-a
among primates immunised with endotoxin after treating
them with leptin. The lack of an association between leptin
and inflammation found in this study may be due to the low
grade of inflammation and cytokine concentrations seen in
obesity, which may not provide adequate statistical power
relative to that reported in acute inflammation states or in
cell lines. Overall, these findings suggest that, in this popu-
lation, leptin may not be directly involved in the pathway
that leads to chronic inflammation among obese individuals.
The reduced odds of higher levels of the inflammatory mar-
kers TNF-a, IL-6 and IL-12 among women with higher Zn con-
centration is similar to the findings by Bao et al.(47). They
reported that Zn supplementation of elder subjects was associ-
ated with decreased concentrations of plasma inflammatory
Table 1. Physical and biochemical characteristics of the subjects
(Mean values and standard deviations)
Normal (n 52)
Overweight
(n 104) Obese (n 124) Total (n 280)
Mean SD Mean SD Mean SD Mean SD
Age (years) 33·9a 6·8 37·2a 7·8 38·2b 7·5 37 7·5
Weight (kg) 53·9a 4·9 62·9b 5·1 78·9c 10·4 68·2 12·7
BMI (kg/m2) 22·9a 1·5 27·5b 1·4 34·5c 4·1 29·7 5·5
Abdominal fat (%) 36·9a 5·1 42·9b 3·7 47·1c 4·1 43·6 5·6
Waist circumference (cm) 76·5a 15·1 86·3b 4·9 99·9c 8·9 90·3 11·5
Waist:height ratio 0·4a 0·03 0·5b 0·03 0·6c 0·1 0·5 0·1
Vitamin A (mg/l) 462b 109 501a 70 481 119 485 114
Vitamin E:lipids (mmol/mmol) 2·9 0·8 2·8 0·9 2·8 0·7 2·8 0·8
Vitamin C (mg/ml) 5·1 2·2 5·4 2·2 5·4 2·2 5·2 2·2
Zn (mg/l) 1·2 0·5 1·2 0·6 1·2 0·7 1·2 0·6
Leptin (pg/ml) 16·1a 9·6 25·7b 11·1 44·6c 18·4 32·2 18·5
CRP (mg/l) 2·7a 3·3 4·3b 3·1 6·7c 3·7 5·1 3·5
CRP, C-reactive protein.
a,b,c Mean values within a row with unlike superscript letters were significantly different (Tukey test, P,0·05).
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cytokines. Much research has been carried out about Zn
concerning the pathways that may be involved in the associ-
ation of Zn and the immune system; there is still no consensus.
However, the strongest theory involves Zn regulation of
Zn-dependent enzymes related with the immune system(48).
One of these enzymes is ZAG, a soluble cytokine that
down-regulates the expression of TNF-a. Bao et al.(49) con-
sider ZAG an important beneficial factor for obesity(49). The
expression of ZAG is down-regulated in obese subjects(50).
Thus, Zn may protect against chronic inflammation through
the expression of ZAG and its down-regulation effect on
TNF-a.
In the present study, the odds of having higher levels of
the anti-inflammatory cytokine IL-10 was also reduced with
high Zn concentrations. Similarly, it has been observed in
both in vitro and human studies that Zn supplementation
decreases IL-10 concentrations(51,52). In addition, obese indivi-
duals have increased pro-inflammatory and anti-inflammatory
cytokines(53). Obese women, for example, before a gastric
bypass, had significantly higher IL-10 concentrations com-
pared to normal-weight women(54). TNF-a, IL-6 and IL-10
concentrations were significantly higher in obese patients
with heart failure than in non-obese patients with mild heart
failure(55). This has also been observed in patients during an
infectious disease episode, where the concentrations of the
anti-inflammatory cytokine IL-10 are increased in response
to increased inflammatory cytokine concentrations in order
to minimise damage to the host and to avoid tissue damage.
This simultaneous response then allows the immune response
to return to homeostasis once the infection or the antigen is
cleared(56). Something similar might be occurring in obese
or overweight individuals, or with Zn deficiency, where elev-
ated concentrations of IL-10 may be part of a mechanism to
counteract the effect of the pro-inflammatory cytokines(53).
The anti-inflammatory effect of IL-10 has been attributed to
its ability to inhibit the maturation of antigen-presenting
cells, but preserving the capacity of the cells to load the
antigens. Also, it has been suggested that it may produce a
pro-inflammatory response when antigen-loaded antigen-
presenting cells activate local immune responses(57). Thus, Zn
concentrations may play an important role in the pleiotropic
effects of IL-10.
Vitamin A is recognised to down-regulate the expression of
inflammation markers and promote a Th2 immune response
by binding with its membrane receptor retinoic acid
receptor-a that inhibits the production of interferon-g, a
mediator of other inflammation markers(16,58). In this study,
higher concentrations of vitamin A are associated with
decreased odds of having higher levels of inflammation mar-
kers, although this association is only found for the cytokines
IL-1 and IL-12 and is not as great as that seen with Zn. When
adjusting for obesity, no effect was found between vitamin A
concentrations and the levels of inflammation markers.
These results may reflect the fact that subjects in this study
were not vitamin A-deficient. In vitamin A deficiency, there
is an increase of pro-inflammatory cytokines that promotes a
Th1-type inflammatory response, while the production of
anti-inflammatory cytokines, such as IL-10, is reduced(59,60).T
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For example, in Indonesian children, vitamin A deficiency was
associated with a higher Th1 response(61). Similarly, the pro-
duction of IL-10 was negatively associated with vitamin A
stores in adult men(62). Thus, vitamin A deficiency increases
the production of pro-inflammatory cytokines and reduces
the concentration of anti-inflammatory cytokines.
Vitamin C and vitamin E:lipids were not associated with any
of the cytokines studied. Findings on the relationship between
vitamin C and vitamin E with inflammatory markers have been
inconsistent(18–20,63–66). For example, intakes of vitamin C and
vitamin E were not associated with CRP or IL-6 in 5181 partici-
pants from the Multi-Ethnic Study of Atherosclerosis(64). In
contrast, Mah et al.(65) found an inverse relationship between
vitamin C status and inflammatory markers among obese men
compared with a group of lean adult men in a cross-sectional
study, but found no association between vitamin E status
and CRP concentrations or inflammatory cytokines. Similarly,
Wannamethee et al.(19) reported that vitamin C status was
inversely associated with CRP concentrations and lower endo-
thelial dysfunction in men with no history of CVD or diabetes.
These epidemiological studies show that vitamin C status is
associated with CRP while no associations have been found
between vitamin C status and vitamin E status with the inflam-
matory cytokine response, similar to the findings in the
present study.
Supplementation studies have also reported mixed results.
Bruunsgaard et al.(66) found no difference in the concentration
of IL-6 or TNF-a among adult men supplemented with vitamins
C and E for 36 months compared to men who received a pla-
cebo. In contrast, Block et al.(20) reported that vitamin C sup-
plementation for 2 months was associated with a 24 %
reduction in plasma concentrations of the inflammatory
marker CRP. Increases in vitamin E plasma concentrations
after supplementing with vitamin E and vitamin C for
2 weeks were associated with lower TNF-a concentrations
in adult men with impaired fasting glucose(67). These inconsis-
tencies regarding the effect of vitamin E on inflammation may
be due to the different forms of this vitamin that are found in
the diet or given as supplements. Berdnikov et al.(18), for
example, reported that the a-tocopherol and D-a-tocopherol
isoforms of vitamin E have opposing immunoregulatory
effects on the inflammatory response. The lack of consistency
in the clinical trials may also be explained by the differences in
the supplementation period that range from 2 weeks to 3
years and/or the doses given. More studies are needed to
understand the effect of vitamin C and vitamin E on inflamma-
tory markers.
A number of methodological limitations of our study need
to be addressed. The cross-sectional design of the study com-
plicates efforts to determine causality between body compo-
sition and obesity, serum micronutrient concentrations and
inflammatory cytokines. For example, it is not possible to
determine whether elevated inflammatory cytokines may be
affecting serum micronutrient concentrations or whether
micronutrient concentrations are affecting inflammatory cyto-
kine levels. The effects of inflammation on micronutrient
concentrations were partly controlled by including CRP in all
the models. There were no significant differences in theT
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associations between models that included CPR compared
to models that did not include this inflammatory marker,
suggesting that micronutrient concentrations could be affect-
ing inflammatory cytokine levels.
Associations were found between specific micronutrient
serum concentrations and the odds of having higher con-
centration of inflammatory markers. The findings in the
present study suggest that micronutrients play a different
role in low-grade chronic inflammation among individuals
with differing degrees of adiposity and obesity. Overall,
it was found that higher Zn concentration is associated with
reduced risks of higher concentration of inflammation mar-
kers. These results are preliminary and so must be interpreted
with caution. It is important to continue addressing the
relationship between these micronutrients and the inflam-
matory response especially among populations that differ in
the prevalence of overweight and obesity. Such efforts will
determine whether such relationships change with changing
adiposity, and so establish how specific nutrients may be
interacting with adipose tissue to regulate the production
of inflammatory cytokines and so modify low-grade inflam-
mation occurring in obesity.
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